Category: Immunoassay

Immunoassay

Graphene-Based Biosensor Paves way for Diagnostics

A graphene-based biosensor with a molecular carbon intermediate layer has been developed to detect specific biomarkers.

Immunoassay

Werfen Receives CE Mark for Aptiva Antiphospholipid Syndrome Reagents

Werfen received CE mark for its Aptiva Antiphospholipid Syndrome IgG and IgM reagents under the EU's IVDR.

Immunoassay

FDA Clears Thermo Fisher Immunoassay for Neuroendocrine Cancer Patients

The U.S. FDA cleared the chromogranin A test and immunoassay for the assessment of tumor progression in GEP-NET patients.

Immunoassay Instrumentation

Anbio Launches CLIA Analyzer for Comprehensive Clinical Testing

The ADL i1910 utilizes a direct chemiluminescence method based on acridinium ester to ensure accurate and reliable results across a wide array of applications.

Immunoassay Reagents & test Kits

T2Biothreat Panel FDA 510(k) Submission Announced

T2 Biosystems, Inc.,has submitted a 510(k) premarket notification to the FDA for the Company’s T2Biothreat Panel.

Rapid Assays

Companies Partner on Alzheimer’s Disease Diagnostic Using Optimer Binders

Aptamer Group plc and Neuro-Bio have developed Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer’s disease.